Immunization schedule for 81 vaccines (Anthrax, aP, BCG, bOPV, , CHOLERA, deworming, Dip, Diphteria, DT, DTaP, , DTaPHepBIPV, DTaPHib, DTaPHibHepB, DTaPHibHepBIPV, DTaPHibIPV, DTaPIPV, DTIPV, DTwP, DTwPHepB, , DTwPHib, DTwPHibHepB, HepAHepB, HepA_Adult, HepA_Inactd, HepA_LiveAtd, HepA_Pediatric, HepB_Adult, HepB_BD, HepB_Pediatric, HepB_Pediatric, HFRS, HIB, HIB, HibMenC, HPV, Influenza, Influenza_Adult, Influenza_Pediatric, IPV, JE_Inactd, JE_LiveAtd, leptospirosis, Measles, MenA, MenAC, MenACW, MenACWY-135 conj, MenACWY-135 ps, MenA_conj, MenB, MenBC, MenC_conj, MM, MMR, MMRV, MR, Mumps, OPV, plague, Pneumo_conj, Pneumo_ps, Rabies, Rotavirus, RTS,S, Rubella, TBE, Td, Tdap, Tdap, TdaPIPV, TdIPV, Tetanus, TT, Tularemia, Typhoid, TyphoidHepA, Typhoid_conj, Typhoid_ps)
For 1 country (USA)
and for no specific region.
27 rows
|
| Country |
Antigens |
Description |
Schedules |
Entire country |
Comments |
Americas
|
|
United States of America
|
CHOLERA
|
Cholera vaccine
|
18 years;
|
Yes
|
|
|
|
DT
|
Tetanus and diphtheria toxoid childrens' dose
|
2, 4, 6 months; 4 years;
|
Yes
|
contraindication to pertussis component
|
|
|
DTaP
|
Diphtheria and tetanus toxoid with acellular pertussis vaccine
|
2, 4, 6, 15 months; 4 years;
|
Yes
|
|
|
|
DTaPHepBIPV
|
Diphtheria and Tetanus and Pertussis and Hepatitis B and Polio
|
2, 4, 6 months;
|
Yes
|
|
|
|
DTaPHibHepBIPV
|
Hexavalent diphtheria, tetanus toxoid with acellular pertussis, Hib, hepatitis B and IPV vaccine
|
2, 4, 6 months;
|
Yes
|
Planned introduction in 2021
|
|
|
DTaPHibIPV
|
Diphtheria and tetanus toxoid with acellular pertussis, Hib and IPV vaccine
|
2, 4, 6, 15 months;
|
Yes
|
|
|
|
DTaPIPV
|
Diphtheria and tetanus toxoid with acellular pertussis, and IPV vaccine
|
4 years;
|
Yes
|
|
|
|
HepA_Adult
|
Hepatitis A adult dose vaccine
|
19 years; +6 months;
|
Yes
|
|
|
|
HepA_Pediatric
|
Hepatitis A pediatric dose vaccine
|
12, 18 months;
|
Yes
|
|
|
|
HepB_Adult
|
Hepatitis B adult dose vaccine
|
19 years; +1, +4 months;
|
Yes
|
|
|
|
HepB_Pediatric
|
Hepatitis B pediatric dose vaccine
|
birth; 1, 6 months;
|
Yes
|
|
|
|
Hib
|
Haemophilus influenzae type b vaccine
|
2, 4, 6, 12 months;
|
Yes
|
|
|
|
HPV
|
Human Papillomavirus vaccine
|
11-12 years; +6 months;
|
Yes
|
females and males; if 1st dose is administered at <15 years and no risk groups then x2 doses with interval 6-12 months; if the 1st dose is administered >=15 years or for risk groups x3 doses with an interval of 0, 1, 6 months
|
|
|
Influenza_Adult
|
Influenza adult dose vaccine
|
>=18 years;
|
Yes
|
and adults with chronic conditions, older persons, pregnant women, health care workers, other risk groups
|
|
|
Influenza_Pediatric
|
Influenza pediatric dose vaccine
|
>=6 months;
|
Yes
|
and children with chronic conditions
|
|
|
IPV
|
Inactivated polio vaccine
|
2, 4, 6 months; 4 years;
|
Yes
|
|
|
|
JE_Inactd
|
Japanese encephalitis inactivated vaccine
|
2, +1 months;
|
Yes
|
|
|
|
MenACWY-135 conj
|
Meningococcal ACWY-135 conjugate vaccine
|
11, 16, +5 years;
|
Yes
|
|
|
|
MenB
|
|
10 years; +1, +6 month;
|
Yes
|
high-risk groups for invasive meningococcal disease
|
|
|
MMR
|
Measles mumps and rubella vaccine
|
12 months; 4 years;
|
Yes
|
|
|
|
MMRV
|
Measles, mumps, rubella and varicella vaccine
|
12 months; 4 years;
|
Yes
|
|
|
|
Pneumo_conj
|
Pneumococcal conjugate vaccine
|
2, 4, 6, 12 months;
|
Yes
|
|
|
|
Pneumo_ps
|
Pneumococcal polysaccharide vaccine
|
65 years;
|
Yes
|
|
|
|
Rotavirus
|
Rotavirus vaccine
|
2, 4, 6 months;
|
Yes
|
2 or 3 doses depending on vaccine/risk group
|
|
|
Td
|
Tetanus and diphtheria toxoid for older children / adults vaccube
|
21 years;
|
Yes
|
|
|
|
Tdap
|
Tetanus and diphtheria toxoids and acellular pertussis vaccine
|
11 years;
|
Yes
|
Updated JRF received 24/Jun/2020
|
|
|
Typhoid_ps
|
Typhoid fever polysaccharide vaccine
|
2 years;
|
Yes
|
at-risk persons
|
|
